 |
Experts InSightAuthor: American Academy of Ophthalmology
Practical, topical conversations with experts across the spectrum of ophthalmology. Subscribe for the latest information, evidence-based practice standards, and innovations in eye care, from the American Academy of Ophthalmology. Language: en Genres: Health & Fitness, Medicine Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
Retina Clinical Trial Update 2026
Thursday, 29 October, 2026
Retina is producing Phase 3 results faster than ever, but FDA approval doesn't necessarily convey how a drug will fit into practice. Dr. Ehsan Rahimy joins host Dr. Jay Sridhar to unpack recent and somewhat puzzling trial results involving tyrosine kinase inhibitors, IL-6 inhibition, and the Wnt signaling pathway. They then confront the harder problem: When every trial uses a different population, comparator, and dosing scheme—and none tests against today's second-generation anti-VEGF agents—real-world practice is often shaped by anecdote rather than evidence. For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.
